The epidermal growth factor receptor (EGFR) is frequentlymutatedin human cancer, most notably non-small-cell lung cancer and glioblastoma.While many frequently occurring EGFR mutations are known to conferconstitutive EGFR activation, the situation is less clear for rarelydetected variants. This evidence concerns the gene EGFR and cancer.